You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Immunol., 02 January 2026

Sec. Molecular Innate Immunity

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1770238

Correction: Manganese mediates antiviral effects by driving an ATM-TBK1 phosphorylation signaling pathway

  • 1. Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD, United States

  • 2. Center for Infectious Disease Research, George Mason University, Manassas, VA, United States

Article metrics

View details

911

Views

30

Downloads

Author “Sylvain Laverdure” was erroneously assigned to affiliation “Center for Infectious Disease Research, George Mason University, Manassas, VA, United States”. This affiliation needs to be removed for author “Sylvain Laverdure”.

The Data Availability statement was erroneously given as “Publicly available datasets were analyzed in this study. This data can be found here: Microscopy data analyzed in this article have been deposited at GEO previously and are publicly available. Accession number is GSE214181”. The correct Data Availability statement is “Publicly available datasets were analyzed in this study. This data can be found here: Microarray data analyzed in this article have been deposited at GEO previously and are publicly available. Accession number is GSE214181”.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

manganese, ATM, TBK1, phosphorylation, antiviral immunity

Citation

Sui H, Wiscovitch-Russo R, Cachaco S, Yang J, Bruchey W, Laverdure S, Chen Q and Imamichi T (2026) Correction: Manganese mediates antiviral effects by driving an ATM-TBK1 phosphorylation signaling pathway. Front. Immunol. 16:1770238. doi: 10.3389/fimmu.2025.1770238

Received

17 December 2025

Accepted

18 December 2025

Published

02 January 2026

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Hongyan Sui,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics